Cargando…
International Price Comparisons of Anticancer Drugs: A Scheme for Improving Patient Accessibility
Background: The demand for implementing a new listing scheme to expedite patient access to novel oncology drugs has increased in South Korea. This study was conducted to compare the prices of anticancer drugs between eight countries and to explore the feasibility of a ‘pre-listing and post-evaluatio...
Autores principales: | Jung, Jae Ho, Kim, Dae Jung, Suh, Kangho, You, Jaeeun, Lee, Je Ho, Joung, Kyung In, Suh, Dong Churl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830510/ https://www.ncbi.nlm.nih.gov/pubmed/33466893 http://dx.doi.org/10.3390/ijerph18020670 |
Ejemplares similares
-
Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility
por: Lee, Seung Mi, et al.
Publicado: (2021) -
Improving Patient Access to New Drugs in South Korea: Evaluation of the National Drug Formulary System
por: Yoo, Seung-Lai, et al.
Publicado: (2019) -
Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand
por: Limwattananon, Chulaporn, et al.
Publicado: (2019) -
Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China
por: Mingge, Xia, et al.
Publicado: (2023) -
Survival outcomes of double- and triple-sequential targeted therapy in patients with metastatic renal cell carcinoma: a retrospective comparison
por: Kim, Sung Han, et al.
Publicado: (2017)